Videos

Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.

Patient stratification, demographic representations, and plasma collection could aid the pursuit for an efficacious prophylaxis.

A summary of Contagion's top stories for May 15, 2020.

Elizabeth Leung, PharmD, shares SIDP's educational efforts surrounding COVID-19 treatment.

A briefing on the day's top stories.

In the first part of a discussion with the medical oncologist from UPMC Hillman Cancer Center, Brufsky discusses the potential role of hyperglycemia in severity of COVID-19.

A summary of today's top stories.

Paul Sax, MD, discusses remdesivir, scientific literature in the age of COVID-19, and the pandemic's long-lasting effects on the future of health care.

What is the hopeful expectation of the new candidates, relative to previously developed vaccines?

Rodney E. Rohde, PhD, discusses the challenges our shortage of medical laboratory specialists creates for the COVID-19 response.

Preventive medicine expert William Schaffner, MD, discusses what it will take for investigators to properly assess and manufacture a vaccine.

A quick video summary of today's COVID-19 headlines.

A quick summary of our daily COVID-19 coverage.

Managing editor Kevin Kunzmann provides a summary of our daily COVID-19 coverage.

Michael B. Edmond, MD, MPH, MPA, MBA, explains his hypothesis that universally adopting face shields could help cut the transmissibility of COVID-19.

Contagion Editor in Chief Jason Gallagher, PharmD, discusses the new authorization for the controversial antiviral therapy.

A brief summary of our daily COVID-19 coverage.

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

In part 1 of our interview, Ryan W. Stevens, PharmD, BCIDP, provides an overview of how convalescent plasma has been used to treat infectious diseases including coronaviruses.

Stephen Klasko, MD, MBA, CEO of Thomas Jefferson University Hospitals, discusses what COVID-19 has taught hospitals about preparing for pandemics.

Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the complexity of balancing hospital treatment priorities during the COVID-19 pandemic.

Stephen Klasko, MD, Chief Executive Officer of Thomas Jefferson University Hospitals, discusses the impact of COVID-19 on hospitals around the country.

Lucas Schulz, PharmD, BCPS, AQ-ID, discusses how he is preparing for COVID-19 as a clinical pharmacist working in Wisconsin.

Paul Blair, MD, MHS, MSPH, discusses the needs of frontline health care workers.

Jeannette Bouchard, PharmD, discusses how ID pharmacists are taking on new responsibilities and working collaboratively to respond to COVID-19.

Paul Blair, MD, MHS, MSPH, discusses the changes to everyday life as an ID specialist brought on by COVID-19.

Ramy Elshaboury, PharmD, BCPS, AQ ID, discusses the process of putting COVID-19 guidance in place using currently available literature and data.

Thomas Dilworth, PharmD, shares tips and resources that can help busy clinicians stay engaged and up to date during the COVID-19 pandemic.

Matthew Davis, PharmD, provides an overview on the agent remdesivir.